Small interfering RNAs (siRNAs) targeting circ_0020378 (si-circ_0020378), COL1A1 (si-COL1A1), miR-339-3p inhibitor and mimic, and their respective negative controls (si-NC, inhibitor NC, and mimic NC) were purchased from GenePharma, China. Recombinant lentiviruses (multiplicity of infection [MOI] = 50) carrying short hairpin RNAs (shRNAs) targeting either circ_0020378 (sh-circ) or sh-NC were purchased from GenePharma. Lipo3000 was used to introduce synthetic nucleotides (siRNAs, mimics, and inhibitors) into Saos-2 and HOS cells. After a 48-h transfection period, the efficacy of transfection was verified by RT-qPCR. For shRNA lentivirus infection, approximately 80% confluent Saos-2 cells were incubated with the virus particles (MOI = 50). After 14 days, the survivors were screened by adding 0.5 μg/mL puromycin. Positive monoclonal cells were expanded and verified using RT-qPCR.
Saos 2
Saos-2 is a human osteosarcoma cell line. It is a well-established model for the study of osteoblast-like cells and bone-related research.
Lab products found in correlation
13 protocols using saos 2
Osteoblast and Osteosarcoma Cell Culture
Small interfering RNAs (siRNAs) targeting circ_0020378 (si-circ_0020378), COL1A1 (si-COL1A1), miR-339-3p inhibitor and mimic, and their respective negative controls (si-NC, inhibitor NC, and mimic NC) were purchased from GenePharma, China. Recombinant lentiviruses (multiplicity of infection [MOI] = 50) carrying short hairpin RNAs (shRNAs) targeting either circ_0020378 (sh-circ) or sh-NC were purchased from GenePharma. Lipo3000 was used to introduce synthetic nucleotides (siRNAs, mimics, and inhibitors) into Saos-2 and HOS cells. After a 48-h transfection period, the efficacy of transfection was verified by RT-qPCR. For shRNA lentivirus infection, approximately 80% confluent Saos-2 cells were incubated with the virus particles (MOI = 50). After 14 days, the survivors were screened by adding 0.5 μg/mL puromycin. Positive monoclonal cells were expanded and verified using RT-qPCR.
Culturing Human Osteoblast and Osteosarcoma Cells
Cell culture: HfoB1.19 cells, MG63, U2OS, and Saos-2 OS cells were cultured in DMEM medium supplemented with 10% fetal bovine serum (FBS). The media were purchased from Procell Life Science & Technology Corporation (Wuhan, China), and the FBS were purchased from Hyclone (South Logan, UT, USA). The medium contained penicillin (100 U/mL) and streptomycin (100 U/mL). All cell lines were grown in a 37°C incubator with 5% CO2.
Osteosarcoma Cell Lines Characterization
Silencing PTN in Osteoblast and OSA Cells
Osteosarcoma Tissue and Cell Line Analysis
Osteosarcoma cell lines (U-2OS, MG-63, and Saos-2) and a normal osteoblast cell line (hFOB 1.19) were purchased from Procell Life Science & Technology (Wuhan, Hubei, China), and verified using STR genotyping. U-2OS and Saos-2 cells were cultured in McCoy's 5A medium supplemented with 10% FBS (fetal bovine serum) and 1% penicillin and streptomycin. MG-63 cells were grown in minimum essential medium supplemented with 10% FBS and 1% penicillin and streptomycin. hFOB 1.19 cells were cultured in F12 medium and Dulbecco’s modified Eagle medium supplemented with 0.3 mg/ml G418, 10% FBS, and 1% penicillin and streptomycin. hFOB 1.19 cells were maintained in an incubator at 34°C with 5% CO2, and all other cells were maintained at 37°C with 5% CO2.
Investigating Osteosarcoma Cell Signaling
Osteosarcoma and Osteoblast Cell Culture
Establishing Osteosarcoma-Resistant Cell Lines
Culturing Human Cell Lines
Knockdown of DEPDC1 and Overexpression of KIF4A in Osteosarcoma Cells
To knock down DEPDC1 expression and overexpress KIF4A expression in osteosarcoma cells, short hairpin (sh)RNA targeting ANGPT2 (sh-DEPDC1#1 and sh-DEPDC1#2), pcDNA3.1-KIF4A as well as corresponding negative control (sh-NC) and pcDNA3.1-NC were obtained from RIBIO (Guangzhou, China). When OS cells were reached to about 80% confluence, OS cells were transfected with different vectors using Lipofectamine 3000 according to the manufacturer’s protocol. The transfection efficiency was confirmed by RT-qPCR and western blot 48 h later.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!